These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24907231)

  • 21. Dysphagia, malnutrition and gastrointestinal problems in patients with mitochondrial disease caused by the m3243A>G mutation.
    de Laat P; Zweers HE; Knuijt S; Smeitink JA; Wanten GJ; Janssen MC
    Neth J Med; 2015 Jan; 73(1):30-6. PubMed ID: 26219939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases.
    Lovadi E; Csereklyei M; Merkli H; FüLöp K; Sebők Á; Karcagi V; Komoly S; Pál E
    Muscle Nerve; 2017 Apr; 55(4):564-569. PubMed ID: 27489983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lecocytes mutation load declines with age in carriers of the m.3243A>G mutation: A 10-year Prospective Cohort.
    Langdahl JH; Larsen M; Frost M; Andersen PH; Yderstraede KB; Vissing J; Dunø M; Thomassen M; Frederiksen AL
    Clin Genet; 2018 Apr; 93(4):925-928. PubMed ID: 29266179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preimplantation genetic diagnosis in mitochondrial DNA disorders: challenge and success.
    Sallevelt SC; Dreesen JC; Drüsedau M; Spierts S; Coonen E; van Tienen FH; van Golde RJ; de Coo IF; Geraedts JP; de Die-Smulders CE; Smeets HJ
    J Med Genet; 2013 Feb; 50(2):125-32. PubMed ID: 23339111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers.
    Koene S; de Laat P; van Tienoven DH; Weijers G; Vriens D; Sweep FC; Timmermans J; Kapusta L; Janssen MC; Smeitink JA
    JIMD Rep; 2015; 24():69-81. PubMed ID: 25967227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six-year prospective follow-up study in 151 carriers of the mitochondrial DNA 3243 A>G variant.
    de Laat P; Rodenburg RR; Roeleveld N; Koene S; Smeitink JA; Janssen MC
    J Med Genet; 2021 Jan; 58(1):48-55. PubMed ID: 32439810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and progression of diabetes in mitochondrial disease.
    Whittaker RG; Schaefer AM; McFarland R; Taylor RW; Walker M; Turnbull DM
    Diabetologia; 2007 Oct; 50(10):2085-9. PubMed ID: 17653689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation.
    Pyle A; Taylor RW; Durham SE; Deschauer M; Schaefer AM; Samuels DC; Chinnery PF
    J Med Genet; 2007 Jan; 44(1):69-74. PubMed ID: 16950816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
    Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
    Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently.
    Li X; Fan X; Ren F; Zhang Y; Shen C; Ren G; Sun J; Zhang N; Wang W; Ning G; Yang J
    Diabetes Res Clin Pract; 2011 Jul; 93(1):10-6. PubMed ID: 21596453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Droplet digital polymerase chain reaction to measure heteroplasmic m.3243A>G mitochondrial mutations.
    Matsumoto S; Uchiumi T; Noda N; Ueyanagi Y; Hotta T; Kang D
    Lab Med; 2024 Mar; 55(2):227-233. PubMed ID: 37478467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A maternally inherited diabetes and deafness patient with the 12S rRNA m.1555A>G and the ND1 m.3308T>C mutations associated with multiple mitochondrial deletions.
    Mezghani N; Mnif M; Mkaouar-Rebai E; Kallel N; Charfi N; Abid M; Fakhfakh F
    Biochem Biophys Res Commun; 2013 Feb; 431(4):670-4. PubMed ID: 23357420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How the most common mitochondrial DNA mutation (m.3243A>G) vanishes from leukocytes: a mathematical model.
    Veitia RA
    Hum Mol Genet; 2018 May; 27(9):1565-1571. PubMed ID: 29474538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease.
    Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P
    J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status.
    Lee Y; Lim S; Hong ES; Kim JH; Moon MK; Chun EJ; Choi SI; Kim YB; Park YJ; Park KS; Jang HC; Choi SH
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):57-64. PubMed ID: 23278761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle computed tomography patterns in patients with the mitochondrial DNA mutation 3243A>G.
    Kärppä M; Mahjneh I; Karttunen A; Tolonen U; Majamaa K
    J Neurol; 2004 May; 251(5):556-63. PubMed ID: 15164188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases.
    Debray FG; Lambert M; Chevalier I; Robitaille Y; Decarie JC; Shoubridge EA; Robinson BH; Mitchell GA
    Pediatrics; 2007 Apr; 119(4):722-33. PubMed ID: 17403843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease.
    Davis RL; Liang C; Edema-Hildebrand F; Riley C; Needham M; Sue CM
    Neurology; 2013 Nov; 81(21):1819-26. PubMed ID: 24142477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.